RSCI (Redwood Scientific Technologies) DeferredTaxAndRevenue: $0.00 Mil (As of Dec. 2023)


What is Redwood Scientific Technologies DeferredTaxAndRevenue?

Redwood Scientific Technologies RSCI DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2023.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Redwood Scientific Technologies's current deferred tax and revenue for the quarter that ended in Dec. 2023 was $0.00 Mil.

Redwood Scientific Technologies DeferredTaxAndRevenue Related Terms

Redwood Scientific Technologies DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies DeferredTaxAndRevenue Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
0.00 0.00 0.00 0.00

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Redwood Scientific Technologies (RSCI) has a DeferredTaxAndRevenue of $0.00 Mil as of Dec. 2023. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Redwood Scientific Technologies.
Is Redwood Scientific Technologies' DeferredTaxAndRevenue too high?
Redwood Scientific Technologies' current DeferredTaxAndRevenue is $0.00 Mil.
How does Redwood Scientific Technologies' DeferredTaxAndRevenue compare to RAPH and FLGC?
Redwood Scientific Technologies' DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Redwood Scientific Technologies. Redwood Scientific Technologies's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current DeferredTaxAndRevenue is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.